WEST LAFAYETTE, Ind., Sept. 8, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that a poster about its EC-FV-04 study will be presented at the 17th International Meeting of the European Society of Gynaecological Oncology in Milan, Italy.
